Literature DB >> 15858475

Cutaneous type pemphigus vulgaris: a rare clinical phenotype of pemphigus.

Kazue Yoshida1, Yujiro Takae, Hitoshi Saito, Hiroshi Oka, Akiko Tanikawa, Masayuki Amagai, Takeji Nishikawa.   

Abstract

Pemphigus is an autoimmune blistering disease of the skin, mucous membranes, or both. There are two main categories of pemphigus: pemphigus foliaceus (PF) and pemphigus vulgaris (PV). PV is further subdivided into mucosal dominant and mucocutaneous types, according to the extent of cutaneous lesions. These classes of pemphigus have distinct histopathologic and serologic findings, with most cases falling into these subtypes. We report 4 cases that clinically showed blisters and erosions in the skin only, without mucosal involvement. Histologic examination of cutaneous lesions demonstrated suprabasilar acantholysis, a typical finding for PV. These patients had predominant anti-desmoglein 1 (Dsg1) IgG autoantibodies as well as anti-Dsg3 IgG autoantibodies, as determined by enzyme-linked immunosorbent assay. The desmoglein compensation theory posits that this rare phenotype can be produced by pathogenically weak anti-Dsg3 IgG in the presence of potent anti-Dsg1 IgG autoantibodies. Thus, cutaneous type PV without apparent mucosal involvement is observed as a rare clinical and histologic expression of pemphigus. This expression can be a transient phenotype that may develop from, or evolve into, other subtypes of pemphigus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15858475     DOI: 10.1016/j.jaad.2005.01.106

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  11 in total

1.  Pregnancy-Associated "Cutaneous Type" Pemphigus Vulgaris.

Authors:  Javier Rangel
Journal:  Perm J       Date:  2016

2.  Pemphigus vulgaris with tense bullae.

Authors:  Emilie T Nguyen; Shinko K Lin; Jashin J Wu
Journal:  Perm J       Date:  2015

Review 3.  Pemphigus.

Authors:  Michael Kasperkiewicz; Christoph T Ellebrecht; Hayato Takahashi; Jun Yamagami; Detlef Zillikens; Aimee S Payne; Masayuki Amagai
Journal:  Nat Rev Dis Primers       Date:  2017-05-11       Impact factor: 52.329

4.  Selective Elevation of Antibodies to Desmoglein 1 during the Transition from Mucocutaneous to Cutaneous Type Pemphigus Vulgaris.

Authors:  Haruna Matsuda-Hirose; Kazushi Ishikawa; Mizuki Goto; Yutaka Hatano; Sakuhei Fujiwara
Journal:  Ann Dermatol       Date:  2013-05-10       Impact factor: 1.444

Review 5.  The desmosome and pemphigus.

Authors:  Jens Waschke
Journal:  Histochem Cell Biol       Date:  2008-04-03       Impact factor: 4.304

6.  Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus.

Authors:  Elias Walter; Franziska Vielmuth; Lukas Rotkopf; Miklós Sárdy; Orsolya N Horváth; Matthias Goebeler; Enno Schmidt; Rüdiger Eming; Michael Hertl; Volker Spindler; Jens Waschke
Journal:  Sci Rep       Date:  2017-06-15       Impact factor: 4.379

7.  Involvement of Nail Apparatus in Pemphigus Vulgaris in Ethnic Poles Is Infrequent.

Authors:  Pawel Pietkiewicz; Monika Bowszyc-Dmochowska; Justyna Gornowicz-Porowska; Marian Dmochowski
Journal:  Front Med (Lausanne)       Date:  2018-08-14

8.  The Demographic Attributes, Clinical Features, and Optimal Management of 143 Patients with Pemphigus: A Retrospective Observational Study from a Tertiary Care Center of India.

Authors:  Vikram K Mahajan; Karaninder S Mehta; Jyotshna Sharma; Prabal Kumar; Pushpinder S Chauhan; Ravinder Singh; Sujaya Manvi; Sanket Vashist; Anuj Sharma; Anju L Sharma
Journal:  Indian Dermatol Online J       Date:  2022-03-03

9.  Case report: Documentation of cutaneous only pemphigus vulgaris without history of mucosal lesions in North America.

Authors:  John Baker; Kristina Seiffert-Sinha; Animesh A Sinha
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

10.  Clinical and serological predictors of relapse in pemphigus: a study of 143 patients.

Authors:  G Genovese; C A Maronese; G Casazza; L Corti; L Venegoni; S Muratori; E Berti; D Fanoni; A V Marzano
Journal:  Clin Exp Dermatol       Date:  2021-08-27       Impact factor: 4.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.